Quanterix Corporation Operating Expenses
Quanterix Corporation (QTRX) reported Operating Expenses of $62.10 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-08-10
- Quanterix Corporation operating expenses for the quarter ending 2026-06-30 was $62.10M, a 31.85% increase year-over-year.
- Quanterix Corporation operating expenses for the quarter ending 2026-03-31 was $56.93M, a 38.16% increase year-over-year.
- Quanterix Corporation operating expenses for the quarter ending 2025-12-31 was $44.79M, a 21.25% increase year-over-year.
- Quanterix Corporation operating expenses for the quarter ending 2025-09-30 was $54.53M, a 70.94% increase year-over-year.
- Quanterix Corporation operating expenses for fiscal 2025 was $190.50M, a 40.36% increase from fiscal 2024.
- Quanterix Corporation operating expenses for fiscal 2024 was $135.72M, a 12.90% increase from fiscal 2023.
- Quanterix Corporation operating expenses for fiscal 2023 was $120.22M, a 19.66% decline from fiscal 2022.
- Quanterix Corporation operating expenses for fiscal 2022 was $149.63M, a 23.36% increase from fiscal 2021.
| Period end | Operating Expenses 3 month | Operating Expenses 3 month as first filed | Operating Expenses 6 month | Operating Expenses 6 month as first filed | Operating Expenses 9 month | Operating Expenses 9 month as first filed | Operating Expenses 12 month | Operating Expenses 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $62.10M 10-Q · filed 2026-08-10 | $119.03M 10-Q · filed 2026-08-10 | $163.82M derived: sum of 3 quarters · filed 2026-08-10 | $218.35M derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2026-03-31 | $56.93M 10-Q · filed 2026-05-06 | $101.72M derived: sum of 2 quarters · filed 2026-05-06 | $156.25M derived: sum of 3 quarters · filed 2026-05-06 | $203.35M derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2025-12-31 | $44.79M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $99.32M derived: sum of 2 quarters · filed 2026-03-02 | $146.42M derived: sum of 3 quarters · filed 2026-08-10 | $190.50M 10-K · filed 2026-03-02 | ||||
| 2025-09-30 | $54.53M 10-Q · filed 2025-11-10 | $101.63M derived: sum of 2 quarters · filed 2026-08-10 | $145.71M 10-Q · filed 2025-11-10 | $179.77M derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2025-06-30 | $47.10M 10-Q · filed 2026-08-10 | $48.40M 10-Q · filed 2025-08-07 | $88.31M 10-Q · filed 2026-08-10 | $91.18M 10-Q · filed 2025-08-07 | $125.24M derived: sum of 3 quarters · filed 2026-08-10 | $157.14M derived: sum of 4 quarters · filed 2026-08-10 | ||
| 2025-03-31 | $41.20M 10-Q · filed 2026-05-06 | $42.78M 10-Q · filed 2025-05-12 | $78.14M derived: sum of 2 quarters · filed 2026-05-06 | $110.04M derived: sum of 3 quarters · filed 2026-05-06 | $143.22M derived: sum of 4 quarters · filed 2026-05-06 | |||
| 2024-12-31 | $36.94M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $68.84M derived: sum of 2 quarters · filed 2026-03-02 | $102.02M derived: sum of 3 quarters · filed 2026-03-02 | $135.72M 10-K · filed 2026-03-02 | ||||
| 2024-09-30 | $31.90M 10-Q · filed 2025-11-10 | $65.08M derived: sum of 2 quarters · filed 2025-11-10 | $98.78M 10-Q · filed 2025-11-10 | $131.81M derived: sum of 4 quarters · filed 2025-11-10 | ||||
| 2024-06-30 | $33.18M 10-Q · filed 2025-08-07 | $33.17M 10-Q · filed 2024-08-08 | $66.88M 10-Q · filed 2025-08-07 | $66.76M 10-Q · filed 2024-08-08 | $99.90M derived: sum of 3 quarters · filed 2025-08-07 | $132.12M derived: sum of 4 quarters · filed 2025-08-07 | ||
| 2024-03-31 | $33.70M 10-Q · filed 2025-05-12 | $33.59M 10-Q · filed 2024-05-08 | $66.73M derived: sum of 2 quarters · filed 2025-05-12 | $98.94M derived: sum of 3 quarters · filed 2025-05-12 | $127.35M derived: sum of 4 quarters · filed 2025-05-12 | |||
| 2023-12-31 | $33.02M 10-K/A · filed 2024-12-26 | $65.24M derived: sum of 2 quarters · filed 2024-12-26 | $93.64M derived: sum of 3 quarters · filed 2024-12-26 | $120.22M 10-K · filed 2026-03-02 | $120.35M 10-K · filed 2024-02-29 | |||
| 2023-09-30 | $32.22M 10-K/A · filed 2024-12-26 | $31.55M 10-Q · filed 2023-11-08 | $60.62M derived: sum of 2 quarters · filed 2024-12-26 | $87.19M 10-K/A · filed 2024-12-26 | $86.60M 10-Q · filed 2023-11-08 | $121.23M derived: sum of 4 quarters · filed 2024-12-26 | ||
| 2023-06-30 | $28.40M 10-K/A · filed 2024-12-26 | $28.70M 10-Q · filed 2023-08-08 | $54.98M 10-K/A · filed 2024-12-26 | $55.05M 10-Q · filed 2023-08-08 | $89.01M derived: sum of 3 quarters · filed 2024-12-26 | $137.27M derived: sum of 4 quarters · filed 2024-12-26 | ||
| 2023-03-31 | $26.57M 10-K/A · filed 2024-12-26 | $26.35M 10-Q · filed 2023-05-09 | $60.61M derived: sum of 2 quarters · filed 2024-12-26 | $108.87M derived: sum of 3 quarters · filed 2024-12-26 | $144.15M derived: sum of 4 quarters · filed 2024-12-26 | |||
| 2022-12-31 | $34.04M 10-K/A · filed 2024-12-26 | $82.30M derived: sum of 2 quarters · filed 2024-12-26 | $117.58M derived: sum of 3 quarters · filed 2024-12-26 | $149.63M 10-K · filed 2025-03-17 | $148.51M 10-K · filed 2023-03-06 | |||
| 2022-09-30 | $48.26M 10-K/A · filed 2024-12-26 | $47.55M 10-Q · filed 2022-11-09 | $83.54M derived: sum of 2 quarters · filed 2024-12-26 | $115.59M 10-K/A · filed 2024-12-26 | $113.96M 10-Q · filed 2022-11-09 | $152.73M derived: sum of 4 quarters · filed 2024-12-26 | ||
| 2022-06-30 | $35.28M 10-K/A · filed 2024-12-26 | $33.67M 10-Q · filed 2022-08-08 | $67.33M 10-K/A · filed 2024-12-26 | $66.42M 10-Q · filed 2022-08-08 | $104.47M derived: sum of 3 quarters · filed 2024-12-26 | $134.94M derived: sum of 4 quarters · filed 2024-12-26 | ||
| 2022-03-31 | $32.05M 10-K/A · filed 2024-12-26 | $32.75M 10-Q · filed 2022-05-10 | $69.19M derived: sum of 2 quarters · filed 2024-12-26 | $99.66M derived: sum of 3 quarters · filed 2024-12-26 | $127.21M derived: sum of 4 quarters · filed 2024-12-26 | |||
| 2021-12-31 | $37.14M derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-12-26 | $67.61M derived: sum of 2 quarters · filed 2024-12-26 | $95.16M derived: sum of 3 quarters · filed 2024-12-26 | $121.29M 10-K/A · filed 2024-12-26 | $120.31M 10-K · filed 2022-03-01 | |||
| 2021-09-30 | $30.48M 10-Q · filed 2022-11-09 | $58.02M derived: sum of 2 quarters · filed 2022-11-09 | $84.16M 10-Q · filed 2022-11-09 | $109.14M derived: sum of 4 quarters · filed 2023-03-06 | ||||
| 2021-06-30 | $27.54M 10-Q · filed 2022-08-08 | $53.68M 10-Q · filed 2022-08-08 | $78.66M derived: sum of 3 quarters · filed 2023-03-06 | $97.49M derived: sum of 4 quarters · filed 2023-03-06 | ||||
| 2021-03-31 | $26.14M 10-Q · filed 2022-05-10 | $51.12M derived: sum of 2 quarters · filed 2023-03-06 | $69.95M derived: sum of 3 quarters · filed 2023-03-06 | $87.36M derived: sum of 4 quarters · filed 2023-03-06 | ||||
| 2020-12-31 | $24.98M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | $43.81M derived: sum of 2 quarters · filed 2023-03-06 | $61.23M derived: sum of 3 quarters · filed 2023-03-06 | $79.77M 10-K · filed 2023-03-06 | ||||
| 2020-09-30 | $18.83M 10-Q · filed 2021-11-04 | $36.24M derived: sum of 2 quarters · filed 2021-11-04 | $54.78M 10-Q · filed 2021-11-04 | $73.13M derived: sum of 4 quarters · filed 2022-03-01 | ||||
| 2020-06-30 | $17.41M 10-Q · filed 2021-08-05 | $35.95M 10-Q · filed 2021-08-05 | $54.31M derived: sum of 3 quarters · filed 2022-03-01 | $71.58M derived: sum of 4 quarters · filed 2022-03-01 | ||||
| 2020-03-31 | $18.54M 10-Q · filed 2021-05-06 | $36.89M derived: sum of 2 quarters · filed 2022-03-01 | $54.17M derived: sum of 3 quarters · filed 2022-03-01 | $71.61M derived: sum of 4 quarters · filed 2022-03-01 | ||||
| 2019-12-31 | $18.35M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $35.63M derived: sum of 2 quarters · filed 2022-03-01 | $53.07M derived: sum of 3 quarters · filed 2022-03-01 | $68.44M 10-K · filed 2022-03-01 | ||||
| 2019-09-30 | $17.28M 10-Q · filed 2020-11-06 | $34.72M derived: sum of 2 quarters · filed 2020-11-06 | $50.09M 10-Q · filed 2020-11-06 | $64.71M derived: sum of 4 quarters · filed 2021-03-05 | ||||
| 2019-06-30 | $17.45M 10-Q · filed 2020-08-04 | $32.81M 10-Q · filed 2020-08-04 | $47.43M derived: sum of 3 quarters · filed 2021-03-05 | $60.69M derived: sum of 4 quarters · filed 2021-03-05 | ||||
| 2019-03-31 | $15.36M 10-Q · filed 2020-05-07 | $29.99M derived: sum of 2 quarters · filed 2021-03-05 | $43.24M derived: sum of 3 quarters · filed 2021-03-05 | $54.53M derived: sum of 4 quarters · filed 2021-03-05 | ||||
| 2018-12-31 | $14.62M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-05 | $27.88M derived: sum of 2 quarters · filed 2021-03-05 | $39.16M derived: sum of 3 quarters · filed 2021-03-05 | $49.50M 10-K · filed 2021-03-05 | ||||
| 2018-09-30 | $13.26M 10-Q · filed 2019-11-08 | $24.54M derived: sum of 2 quarters · filed 2019-11-08 | $34.88M 10-Q · filed 2019-11-08 | $44.85M derived: sum of 4 quarters · filed 2020-03-13 | ||||
| 2018-06-30 | $11.28M 10-Q · filed 2019-08-06 | $15.95M 10-Q · filed 2018-08-10 | $21.62M 10-Q · filed 2019-08-06 | $30.64M 10-Q · filed 2018-08-10 | $31.59M derived: sum of 3 quarters · filed 2020-03-13 | $40.55M derived: sum of 4 quarters · filed 2020-03-13 | ||
| 2018-03-31 | $10.34M 10-Q · filed 2019-05-10 | $14.68M 10-Q · filed 2018-05-15 | $20.31M derived: sum of 2 quarters · filed 2020-03-13 | $29.26M derived: sum of 3 quarters · filed 2020-03-13 | $40.94M derived: sum of 4 quarters · filed 2020-03-13 | |||
| 2017-12-31 | $9.97M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13 | $18.93M derived: sum of 2 quarters · filed 2020-03-13 | $30.61M derived: sum of 3 quarters · filed 2020-03-13 | $35.99M 10-K · filed 2020-03-13 | ||||
| 2017-09-30 | $8.95M 10-Q · filed 2018-11-07 | $20.63M derived: sum of 2 quarters · filed 2018-11-07 | $26.02M 10-Q · filed 2018-11-07 | |||||
| 2017-06-30 | $11.68M 10-Q · filed 2018-08-10 | $23.08M 10-Q · filed 2018-08-10 | ||||||
| 2017-03-31 | $11.39M 10-Q · filed 2018-05-15 | |||||||
| 2016-12-31 | $29.46M 10-K · filed 2019-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |